Lazaron Biotechnologies (SA) Ltd

Development and commercialisation of regenerative cell and medicine technologies

Lazaron Biotechnologies is arranged in three divisions, including the Animal Bio-Cell Division, the Regenerative Cell Technology division and Stem Cell Bank division. Lazaron Biotechnologies is establishing the first human cord blood stem cell bank in Africa.

Lazaron signed a joint venture agreement with SA Endovascular Pty Ltd. that is interested in the application of stem cells in the field of cardiovascular and cartilage regeneration.

Daniel Malan Barry, Dr.
Erwin Schwella, Prof.
Johannes Albertus Moolman, Prof.
Jan-Peter Smedema, Dr.
Martin Van Zyl
Nico Ackermann, Financial Director
Harry Minnie, Executive Director

Robert Godke, Prof.
Carola Niesler, Dr.
Rachel Shuttleworth, Dr.
Ernette du Toit, Dr.
J. H. Rossouw, Dr.

C/O John Daniel House
PO Box 1243, Stellenbosch, 7599
South Africa
Phone: +27-21-809-2100
Fax: +27-21-887-8301

Umbilical cord blood is collected directly after birth. Stem cells are cryogenically preserved in the Lazaron storage facility and kept frozen at -196°C in liquid nitrogen. The number of CD34+ cells is determined before the cells are stored for the lifetime of the donor.

The Animal Bio-Cell Division offers regenerative veterinary cell replacement therapy to the race horse industry and is primarily specialised to tendon regeneration. Different reproductive and biotechnology techniques are offered to the animal breeding industry.